ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000131.1|Pyrrolomycin_1 # 1 # 1125 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.679	BGC0000131.1|Pyrrolomycin_1 	1	1125	+	Loose	1000	25.7942	lsaA	24.44	3000300	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic; pleuromutilin antibiotic	antibiotic target protection	lsa-type ABC-F protein	ATGTCTGAGGCACTTGTGACGGCCGACGGGGCAGACGGGGCCGACGGGCACCGCCCCGGCGGGGCCCGCGCTCTGGCGCTGGTCCCGACCAGCGATGTCAAGCAGACCGCGCGCACCTTCAAGTCCGACCAGGAAGTGCGCTGGTGCCCCGGCTGCGGCGACTACGCCATCCTCGCCGCCGTCCAGGGCTTCCTGCCCGAACTCGGCCTCGCCCGCGAGAACATCGTCTTCATCTCCGGCATCGGCTGCTCCTCCCGCTTCCCCTACTACATGAACACCTACGGGATGCACTCCATCCACGGACGCGCACCCGCCATCGCCACCGGCCTCTCAACCAGCCGGCAAGACCTGTCCGTCTGGGTCGTCACCGGCGACGGCGACGCCCTGTCCATCGGCGGCAACCACCTCATCCACGCCCTCCGCCGCAACGTCAACCTCAAAATCCTCCTGTTCAACAACCGCATCTACGGCCTCACCAAAGGCCAGTACTCCCCCACCTCGGAGACCGGGAAAATCACCAAATCCACCCCCATGGGATCCCTGGACACCCCCTTCAACCCCGTCTCCCTCGCCCTCGGAGCCGAAGCCACCTTCGTCGCCCGCACCATCGACTCCGACCGCAAACACCTCACCAACGTCCTGCGCCAAGCCGCCCACCACCCCGGCACCGCCCTCGTCGAGATCTACCAGAACTGCAACATCTTCAACGACGGCGCCTTCGACACCCTCAAAGACAACAACACCGCCGCCCAGGCCCTGATCCCCCTGGAGCACGGCCAGCCCATCCGCTTCGGCACCCCCGCCGCCGACGGCCTGGGCACGCACGGTGTGATCCGCGACCCCCACACCGGCGACCTGCGCATCATCGACGTCACCACCCACGGCACCGACGGCATCCTCACCCACGACGCCCACGCCACCACCCCCACCACCGCCTTCGCCCTCTCCCGCCTCGCCGACCCCGACACCCTCCACCACACCCCCATCGGCGTCTTCCGGGACATCGAGCGGCCTGTCTACGACGCCTCCATGGCGGCCCAGCTCGACCGCGCCATCGAACAGAAGGGGAAAGGCGATCTCGCCGTCCTCCTCGCAGGCGATGACACCTGGACGGTCAAGAACTGA	MSEALVTADGADGADGHRPGGARALALVPTSDVKQTARTFKSDQEVRWCPGCGDYAILAAVQGFLPELGLARENIVFISGIGCSSRFPYYMNTYGMHSIHGRAPAIATGLSTSRQDLSVWVVTGDGDALSIGGNHLIHALRRNVNLKILLFNNRIYGLTKGQYSPTSETGKITKSTPMGSLDTPFNPVSLALGAEATFVARTIDSDRKHLTNVLRQAAHHPGTALVEIYQNCNIFNDGAFDTLKDNNTAAQALIPLEHGQPIRFGTPAADGLGTHGVIRDPHTGDLRIIDVTTHGTDGILTHDAHATTPTTAFALSRLADPDTLHHTPIGVFRDIERPVYDASMAAQLDRAIEQKGKGDLAVLLAGDDTWTVKN	MSKIELKQLSFAYDNQEALLFDQANITMDTNWKLGLIGRNGRGKTTLLRLLQKQLDYQGEILHQVDFVYFPQTVAEEQQLTYYVLQEVTSFEQWKLERELTLLNVDPEVLWRPFSSLSGGEKTKVLLGLLFIEENAFPLIDEPTNHLDLAGRQQVAEYLKKKKHGFILVSHDRAFVDEVVDHILAIEKSQLTLYQGDFSIYEEQKKLRDAFELAENEKIKKEVNRLKETARKKAEWSMNREGDKYGNAKEKGSGAIFDTGAIGARAARVMKRSKHIQQRAETQLAEKEKLLKDLEYIDPLSMDYQPTHHKTLLTVEELRLGYEKNWLFTPISFSINAGEIVGITGKNGSGKSSLIQYLLGDFSGDSEGEATLAHQLTISYVRQDYEDNQGTLSEFAEKNQLDYTQFLNNLRKLGMERAVFTNRIEQMSMGQRKKVEVAKSLSQSAELYIWDEPLNYLDVFNHQQLEALILSVRPAMLVIEHDAHFMKKITDKKIALKS	75.10	gnl|BL_ORD_ID|1191|hsp_num:0	1298			1230	1365	clindamycin; quinupristin; dalfopristin; pleuromutilin
BGC0000131.1|Pyrrolomycin_2 # 1163 # 2602 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.690	BGC0000131.1|Pyrrolomycin_2 	1163	2602	+	Loose	1080	51.2174	rosB	24.85	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGACCGACACACACAAGCACGCGGAATGGATCGTCACCGTCGCGATCGGCGACGTGGCGCTGGTACTCGCGGTAGGAACGCTCTTCGTCCTCCTCGCGCGCCGCGTGAAGCAGCCGGCGGTCATCGGCGAGATCACCGCGGGCATCTGCCTCGGGCCGAGCCTGCTGGGCCTTTTTCCAGGTGACCTTCCACAACGTCTTTTCCCAACCGATGTCAGGCCGTATCTGAATGTCGTCGCCCAGATCGGCCTGCTGCTTTTCATGTTCATCATCGGATGGGAATTCGACTACGCGTCCATGAAGGGGCGGCGCCGCGACGTCGGCACCATCTGGATCTCCGCGGCGGCGCTGCCGGTCGCCATGGGCATGGGCCTCGCGGTCCTGCTGCACGGCTCCAACGACGTGGTCAACGGCAAGTCGGTGCGCATGGTGGACTTCGCGCTCTACCTGGGCATCGCCATGTCCATCGCGGCGTTCCCGGTGCTCGCGCGCATCATCACCGACCACCGGCTGCAACTCACCCGCGTGGGAACGCTGGCGCTGGCGCTGGCCGCGCTGGACGACATCCTCGCCTGGTCGATGCTCGCGATCGTGGTGGCCCTGGTGACGGCCACCGGCACCGGGGGCTTCCTCGGCGTGCTGGGCTGGGGCGCCGTCTACATCCTGGTGATGCTGGTGATCGGCCGCCCCCTCCTGGCCGCGGTGGCCGCCGCTCACCAGCGCGGGCACGCGTACCCTAAACCGTGCCACGCCTCCGGGACGCTCTGCTCGGCCTATGTCACCTCGGAGATCGGCCTGCACGCCATCTTCGGCGCGTTCGTCTTCGGCCTGGTGATGCCGCGCGGGCCGCAGCAGGAGATGTTCCACAACGCGGCGATGGTCCCGCTGGAGCACATCAGCAAGCTGCTGCTGCCGCTGTTCTTCGTCGTCTCCGGCCTTTCGGTGGACCTCACCGCCATGACGGCCGACGGCCTGATCCAGATGTGCGTGATCATCTGCGTGGCCATCACGGGCCAGCTCGGCGGGGTGCTGCTGCCGGCCCGGGTGACCGCCATGAGCAGGCACGACTCCACAATCCTCGGCTTGCTGATGAACACCCGGGGGCTCACCGAACTGGTGATCCTCCACGTCGGTCGCAGCCTGGCCCTGCTCAGCGTCGAACTGTTCACCGCGATGGTGATGATGGCCCTGGTCACGACCGGTATGACCTCCCCCTTCCTGACCATGATGCTGCGGCGCACCAAGCCCCACTCCGAGGCGCGGTGCCACCGCAGGCCGCGGCCGGGGAGCAGGACGGCGGAGCGCGCCGAGTCCCTGCTGCCCCCGGGAACGCCGACTGACCGACCCGCGCGCCCGGCGGCGCGGCCGCACCTGGCCGCCCCGCGCGGGCGGGACGCGGCGCCCCGGGGCCCGCGACCACGATTCGGTGACACAGAGTAA	MTDTHKHAEWIVTVAIGDVALVLAVGTLFVLLARRVKQPAVIGEITAGICLGPSLLGLFPGDLPQRLFPTDVRPYLNVVAQIGLLLFMFIIGWEFDYASMKGRRRDVGTIWISAAALPVAMGMGLAVLLHGSNDVVNGKSVRMVDFALYLGIAMSIAAFPVLARIITDHRLQLTRVGTLALALAALDDILAWSMLAIVVALVTATGTGGFLGVLGWGAVYILVMLVIGRPLLAAVAAAHQRGHAYPKPCHASGTLCSAYVTSEIGLHAIFGAFVFGLVMPRGPQQEMFHNAAMVPLEHISKLLLPLFFVVSGLSVDLTAMTADGLIQMCVIICVAITGQLGGVLLPARVTAMSRHDSTILGLLMNTRGLTELVILHVGRSLALLSVELFTAMVMMALVTTGMTSPFLTMMLRRTKPHSEARCHRRPRPGSRTAERAESLLPPGTPTDRPARPAARPHLAAPRGRDAAPRGPRPRFGDTE	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	85.08	gnl|BL_ORD_ID|466|hsp_num:0	507			6	882	polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4
BGC0000131.1|Pyrrolomycin_3 # 2698 # 3837 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.721	BGC0000131.1|Pyrrolomycin_3 	2698	3837	+	Loose	150	26.5646	nimJ	27.06	3007112	protein homolog model	n/a	n/a	nitroimidazole antibiotic	antibiotic inactivation	nitroimidazole reductase	GTGGAGTTCGGCTGGACGAAAGAGCAACGGGCCCGCTACGACGAGACCCTCGCCGCCGTGCGCGAGGCGTTCCCCGCCGACGGGCCCCCTTCGACCGACTACTACACCCGTGAGGACTGGAAGCGCCTGGGCGGACTCGGGCTGCTGGGTCTGTCCATTCCGCGCGCGTACGGCGGCGGCGGGCACGGGGCCCTGGACACCGCGCTGCTCGTGGAGGCCCTGGGCCGCGGCTGCGCCGAGACCGGCCTGGTCTTCGGGGCCAGCGCCCACCTGTTCGCGTGCGCCATGCCCGTCGTGGACTACGGCACGGAGGAGCTGCGCAAGCGGATCCTGCCGGGCATCTGCAGCGGCGAGCTGATCGCGGGCAACGCCATGACGGAGGCCGACGCCGGCTCCGACGTGTCCAAGCTGTCCGTCACCGCGACCCGCGCCGACGGGGGCTGGGTGCTCAACGGCGAGAAGAGCTTCGTCAGCAACGGCCCCGCCGCCGACGTCTACACCACCTACGCCACCACCGACCCCAAGGCCGGCCCCTTCGGCGTCACCGGCTTCATCGTGGAGCGCTCCGCGCCGGGCGTCACCGCGAGCGAGCCGTTCGACAAGATGGGCCTGCTCCAGTGCCCGGCCGGCAGCGTCCGCTTCGAGGACACCTTCGTGCCGGACGAGAACGTCCTCGGCGAGCCCGGCCAGGGCGGCTGGATCTTCCAGCACTCCATGGGCTGGGAGCGGGCCTGCCTGTTCGCCGGCTACGTCGGCCTCGCCGACCGGGTGCTGGAGAGCTGCGTCGCCCATGTGAAGGGCCGCCGCCAGTTCGGGAAGCGGCTGTCGGAGTTCCAGGCCGTCTCGCACCGGATCGCGGACATGAAGCTGCGCCTGGAGAGCGCCCGGCTCCTGCTGTACCGCGCCTGCTGGGAGATGGACGAGGGCCTGCCGGCCACCCTGTCCATCGCCCTTTCCAAGCTGGCCGTGTCCGAGGGCGTCGTGGCCAGCGCCCTCGACGCGGTGCGCCTGTTCGGCGGCCGCGGGTACCAGCGCGCCGACCGCATCGAGGCGGCGCTGCGTGACGCGGTGCCGTCGGTGATCTTCTCCGGCACCTCCGACATCCAGCGGCAACTCATCGCAAGGGAGCTCGGCCTATGA	MEFGWTKEQRARYDETLAAVREAFPADGPPSTDYYTREDWKRLGGLGLLGLSIPRAYGGGGHGALDTALLVEALGRGCAETGLVFGASAHLFACAMPVVDYGTEELRKRILPGICSGELIAGNAMTEADAGSDVSKLSVTATRADGGWVLNGEKSFVSNGPAADVYTTYATTDPKAGPFGVTGFIVERSAPGVTASEPFDKMGLLQCPAGSVRFEDTFVPDENVLGEPGQGGWIFQHSMGWERACLFAGYVGLADRVLESCVAHVKGRRQFGKRLSEFQAVSHRIADMKLRLESARLLLYRACWEMDEGLPATLSIALSKLAVSEGVVASALDAVRLFGGRGYQRADRIEAALRDAVPSVIFSGTSDIQRQLIARELGL	MNEFREMRRKRQQLSEEESIAILQKATAGTLALLGDNDYPYAVPISYVYADGRLYFHSALSGHKVDAIRKCDKASFCVIEQDEVHPEKYTTFFRSVIAFGRIHIIEDETEKLETARMLVNRYNPNQEEALQKELENGLSRMLMIRFDIEHLTGKEAIELVRRHQK	229.70	gnl|BL_ORD_ID|4789|hsp_num:0	5785			186	423	metronidazole
BGC0000131.1|Pyrrolomycin_4 # 3834 # 5312 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.725	BGC0000131.1|Pyrrolomycin_4 	3834	5312	+	Loose	1000	152.525	almE	26.43	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAGGTCCATGAGGCTGCACGACCTGCTCATCGAGTCGGCCCGGCGCGATCCCGACGCCGTCGCCGTCCACGGGCCGCAGGGCCCGACGTCCTACTGGGAGCTCGACCGCCTCGCCGACCGCTACGCCGCCGCCCTGACCGGCCGCGGGGTCGCGCGCGGCGACCGGGTGGTGGTCTGGAGCCAGAAGAGCACCGAGGCCATCGCCCTGATGCAGGCGGCGCTGCGCGTCGGCGCCATCTACATCCCCGTCACCGGCTCCAACCCGCCCGCGCGGCTGACGAGGATCGCGGCGAACGCAGGGCCCGCGCTCGTCGTGGCCGACGAGGACGCGGCGTTCCGCGCCCGCAAGGCGAAGTGGGACCGGCGGCCGCTGCTCAGCCTGGACGACGTGCGCCGCAAGGCGTCCGACGGCGCCCGGCCCAAGCCCTACGAGAACGAGCCGGACGAACCCGCCTACATCCTGTACACCTCCGGCTCCACCGGCGACCCGAAGGGCGTGTGCATCAGCCACCGCAACGCCCTGGCCTTCGTGGAGTGGGCGGCGGCCGAGGTGGAGGTGGGCCCGTCGGACCGGCTGTCCAACCACGCCCCGTTCAACTTCGACCTGTCCTGCTTCGACCTGTACGCCGCGTTCCTGGCCGGCGCCTCGGTGCACCTGGTGCCGCAGGAGATCGCGTACGCCCCGGAGCAGCTGGTCCGGTTCATGCGGGACCGCGGGATCACGGTCTGGTACTCGGTGCCGTCCGCGCTGAGCCTGATGATCCGCGAGGGCGGGCTGCTGGACGGGCCGCCCCCGCCGGACCTGCGGGCCTGCCTGTTCGCGGGCGAGCCGTTCGCCATCCACCATGTGCACGCCCTGCGCAAGGGCTGGCCCGGGGTGCGCCTGCTCAACTGGTACGGCCCCACCGAGACCAACGTCTGCACCTCCTACGAGGTCACCGACGCGGACCTGGAGCGCGACCGGCCGGTGCCGATCGGCAAGGCGTGCTCCGGGGACACCGTGATCCTCGACCCGGACGACGGCGGCGAGGGCGAGGTCGTGGTGTCCGGGCCGACCGTGATGCTCGGCTACTGGGGCAGGGAGCCGCAGCGCGGCCCGTACCGCACGGGCGACATCGCCCGTCTCGACCCGCGCGGCGACCTGGAGTACGCGGGCCGCCGCGACCACATGGTGAAGGTCCGCGGCCACCGCATCGAACTCGGCGAGATCGAGGCGGCCATCGCCTCGCTCGACACGGTCTCCGACGTGGCCGTCCTCGTCGTGGGCTCGGGGCTCGAGGCCCAGTTGCACGCCGTCGCCGTCGCCTCGGAGACACACCGTCCGTCGTTGCTCACCGTCAAGCGCGCCTGCGCGGAAAGGCTGCCGACCTACATGATCATCGACAAGCTGCACCTGATCGAGGACCTGCCCAGGACCGCCAATGGCAAGACCGACCGGGCGCGGCTCACCGCGGCCATAGAAGCGGGTGACCTCTGA	MRSMRLHDLLIESARRDPDAVAVHGPQGPTSYWELDRLADRYAAALTGRGVARGDRVVVWSQKSTEAIALMQAALRVGAIYIPVTGSNPPARLTRIAANAGPALVVADEDAAFRARKAKWDRRPLLSLDDVRRKASDGARPKPYENEPDEPAYILYTSGSTGDPKGVCISHRNALAFVEWAAAEVEVGPSDRLSNHAPFNFDLSCFDLYAAFLAGASVHLVPQEIAYAPEQLVRFMRDRGITVWYSVPSALSLMIREGGLLDGPPPPDLRACLFAGEPFAIHHVHALRKGWPGVRLLNWYGPTETNVCTSYEVTDADLERDRPVPIGKACSGDTVILDPDDGGEGEVVVSGPTVMLGYWGREPQRGPYRTGDIARLDPRGDLEYAGRRDHMVKVRGHRIELGEIEAAIASLDTVSDVAVLVVGSGLEAQLHAVAVASETHRPSLLTVKRACAERLPTYMIIDKLHLIEDLPRTANGKTDRARLTAAIEAGDL	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	88.49	gnl|BL_ORD_ID|4935|hsp_num:0	5928			99	1617	colistin A; colistin B
BGC0000131.1|Pyrrolomycin_5 # 5312 # 5875 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.720	BGC0000131.1|Pyrrolomycin_5 	5312	5875	+	Loose	730	25.7942	ceoA	44.44	3003009	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACACTCCAGGCCCAGACCCTCTCCGCCTTCCTCCCCCAGACCCCGGCGGAGCCGCTGCCGTCCGTGGACCTGCAGACGTTCCGCTTCGTGATGGGCTCCTTCGCCAGCGGGGTCTCCGTGGTCCGCGCGGGGACCAAGCAGGACCGCCCGCGCGGGCTGACCTGCTCCGCCATCTGCAGCGTCTCCATCGACCCCCCGCTGCTGCTGTCCAGCGTCAGCAACCGCAGCGGGACGCTGGCGGCGATCCTGGCCACCGGCAAGTTCGCCGTGAACATCCTCGGCGCGCAGGGGCAGGCGGTGTCCCAGCTGTTCGCCTCCGGCGCCGAGGACAAGTTCGAGCGGGTCCGCTGGGAGCCGGGCACGCTGACCGGCAGCCCCCTGTTCCAGGTGACGGTGGCGCACGCGGAGTGCGAGCTGTACAACGCGGTGGAGGCCGGCGACCACACCCTGCTGATCGGCCGGGTGGTCAGCGGCGGCACCGAGCAGGACCGCCTGCCGCTGGCGTACTGGCGCGGTTCCTACCAGCGCGTCTCCCAGGAGAGCACCCCCAGGGTCACCTGA	MTLQAQTLSAFLPQTPAEPLPSVDLQTFRFVMGSFASGVSVVRAGTKQDRPRGLTCSAICSVSIDPPLLLSSVSNRSGTLAAILATGKFAVNILGAQGQAVSQLFASGAEDKFERVRWEPGTLTGSPLFQVTVAHAECELYNAVEAGDHTLLIGRVVSGGTEQDRLPLAYWRGSYQRVSQESTPRVT	MAILRTSRSRIATAAIVTLAVVGLGTFGAMRVSANAPEKAAAPLPEVDVATVVPQTVTDWQSYSGRLEAVEKVDVRPQVSGTIVAVNFKDGALVKKGDVLFVIDPRPYQAEVDRAAAQLAAAQARNGYAQTDWQRAQRLIGDNAIAKRDYDEKQNAAREAKREPEGRRSRAGNGAHQSRLYAHHRAGVGPRVARGNHARQRRVGRRVGRAADDAGIGVADLRVVRRRRADLPAIHQRRAQRPQGAGRARPRERNRLLAQRRDRFGRQPARHVVRHDPRARPLRQRGRHPGPGPLRTREGGRQRAARGAARRRRGDQHRPGQEVRVRRRPAGPRVVSRSAARDAARQPARDRERAVGRRPRGRERHAARASGRAGEAAHGPDDGRRCAVRAVASTAKPAAPAKADS	46.17	gnl|BL_ORD_ID|1576|hsp_num:0	1719			75	156	
BGC0000131.1|Pyrrolomycin_6 # 5984 # 6280 # -1 # ID=1_6;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.721	BGC0000131.1|Pyrrolomycin_6 	5984	6280	-	Loose	2000	22.7126	oqxB	40.91	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATCGAACTCTCCATCACTCGCAGGGTGATACAGGACTGGCTCGTCGAGCGGTTCGCCGCGCACCTCGGCGTGCCCGAGGAGCAGATCGCGGCCGACGCGTACATCGACGAGCTCCCCCTCGACTCCGTCGACGCGGTCGCCGTCGTCGTGGAGCTGGAGCGGTGGTTCGGCCGGCAGCTCGACGTGTGGGAGGTGCGCCGCCACCCCACGATCGGGGAGCTGGCGGACTTCCTGGCGCGGGAGTACGCCCGCCGCCCGGCCGTGCCGAACGCGCGCCCCGCGCCCGCCGCCTGA	MIELSITRRVIQDWLVERFAAHLGVPEEQIAADAYIDELPLDSVDAVAVVVELERWFGRQLDVWEVRRHPTIGELADFLAREYARRPAVPNARPAPAA	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	9.33	gnl|BL_ORD_ID|2152|hsp_num:0	2400			498	564	tigecycline; ciprofloxacin; nitrofurantoin; trimethoprim
